The role of norepinephrine in the treatment of depression

Journal of Clinical Psychiatry

Volumn 60, Issue 9, 1999, Pages 623-631

  Gorman, J M ^a   Nemeroff, C B ^a   Charney, D S ^a  

^a Columbia Physician/Surg Univ Coll ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; MAZINDOL; MIRTAZAPINE; NEFAZODONE; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MULTICENTER STUDY; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; SEROTONINERGIC SYSTEM;

EID: 0032822782     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v60n0909     Document Type: Review

References (43)